Expression of altered α2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension

Authors:
  • MKMala T. Kailasam
    Mala T. Kailasam
  • RPRobert J. Parmer
    Robert J. Parmer
  • HLHiep V. Le
    Hiep V. Le
  • RVRoger Le Verge
    Roger Le Verge
  • BKBrian P. Kennedy
    Brian P. Kennedy
  • MZMichael G. Ziegler
    Michael G. Ziegler
  • PIPaul A. Insel
    Paul A. Insel
  • FWFred A. Wright
    Fred A. Wright
  • DODaniel T. Oʼconnor
    Daniel T. Oʼconnor

Abstract
Essential (hereditary) hypertension is a common, though complex, trait with substantial heritability, but a still-obscure mode of inheritance. In this disorder with relatively late onset, knowledge of phenotypes with earlier penetrance would aid genetic analyses, as well as assessment of risk. Because α2-adrenergic receptor alterations are among the most heritable in experimental genetic hypertension, we hypothesized enhanced expression of α2-adrenergic phenotypic traits in still-normotensive humans at genetic risk of hypertension. We evaluated hemodynamic (blood pressure, cardiac output, systemic vascular resistance, stroke volume, and cardiac contractility) and biochemical (plasma drug, catecholamine, renin, and chromogranin A levels) responses to α2-adrenergic blockade with intravenous yohimbine in 84 normotensive subjects stratified by genetic risk of essential hypertension (67 with positive family histories and 17 with negative family histories of hypertension), as well as 18 subjects with established essential hypertension. Results were evaluated by analysis of variance, normal likelihood ratio test, and by maximum likelihood analysis for bimodality (i.e. mixtures) of response distributions. Blood pressure rose (P Conclusions We conclude that heterogeneous, bimodally distributed hemodynamic responses to α2-adrenergic blockade in subjects with positive family histories of hypertension suggest a discrete subgroup with early expression of perhaps Mendelian traits associated with risk of later development of hypertension. Such phenotypic traits (‘intermediate phenotypes’), with earlier penetrance than hypertension itself, can be evaluated noninvasively, and have a number of implications. They suggest that very early (prehypertensive) pathogenetic alterations in adrenergic control of the circulation occur; they may be especially useful in genetic linkage or association studies of hereditary hypertension; they indicate specific testable candidate (i.e. potentially responsible) genetic loci; their occurrence in only a subset of individuals with positive family histories of hypertension reinforces the hypothesis that hypertension has a heterogeneous pathophysiology; and, finally, they may ultimately allow one to refine estimates of genetic risk of hypertension.

This publication has 41 references indexed in Scilit: